Linked Life Data

20717111

Source:http://linkedlifedata.com/resource/pubmed/id/20717111

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20717111rdf:typepubmed:Citationlld:pubmed
pubmed-article:20717111lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C0205208lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C0123931lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C1176020lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:20717111lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:20717111pubmed:issue7lld:pubmed
pubmed-article:20717111pubmed:dateCreated2010-9-29lld:pubmed
pubmed-article:20717111pubmed:abstractTextSunitinib is a multitargeted, oral tyrosine kinase inhibitor with antitumour and antiangiogenic activity. We investigated the safety and pharmacokinetics of sunitinib in combination with irinotecan in patients with advanced, refractory solid tumours.lld:pubmed
pubmed-article:20717111pubmed:languageenglld:pubmed
pubmed-article:20717111pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20717111pubmed:citationSubsetIMlld:pubmed
pubmed-article:20717111pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20717111pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20717111pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20717111pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20717111pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20717111pubmed:statusMEDLINElld:pubmed
pubmed-article:20717111pubmed:monthSeplld:pubmed
pubmed-article:20717111pubmed:issn1532-1827lld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:ArmandJ PJPlld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:BovenEElld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:TillierCClld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:SoriaJ CJClld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:MassardCClld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:Ruiz-GarciaAAlld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:Countouriotis...lld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:BosiaJJlld:pubmed
pubmed-article:20717111pubmed:authorpubmed-author:HartogVVlld:pubmed
pubmed-article:20717111pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20717111pubmed:day28lld:pubmed
pubmed-article:20717111pubmed:volume103lld:pubmed
pubmed-article:20717111pubmed:ownerNLMlld:pubmed
pubmed-article:20717111pubmed:authorsCompleteYlld:pubmed
pubmed-article:20717111pubmed:pagination993-1000lld:pubmed
pubmed-article:20717111pubmed:dateRevised2011-9-30lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:meshHeadingpubmed-meshheading:20717111...lld:pubmed
pubmed-article:20717111pubmed:year2010lld:pubmed
pubmed-article:20717111pubmed:articleTitleA phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours.lld:pubmed
pubmed-article:20717111pubmed:affiliationDepartment of Medical Oncology, VU University Medical Center, De Boelelaan 1117, Amsterdam NL-1081 HV, The Netherlands. e.boven@vumc.nllld:pubmed
pubmed-article:20717111pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20717111pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20717111pubmed:publicationTypeClinical Trial, Phase Illd:pubmed